1. Samak M.J. Cardiovascular complications in chronic kidney disease // Am. J. Kidney Dis. 2003. Vol. 41. P. 11-17.
2. Милованова Л.Ю., Николаев А.Ю., Милованов Ю.С., Савина Л.Н. Хроническая почечная недостаточность - важнейшая и малоизученная причина сердечнососудистой смертности // Тер. арх. 2006. № 5. С. 51-56.
3. Go A.S., Chertow G.M., Fan D. et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization // New Eng. J. Med. 2004. Vol. 351, N 13. P. 1296-1305. doi: 10.1056/NEJMoa041031.
4. Craver L., Marco M.P., Martinez J.M. et al. Mineral metabolism parameters throughout chronic kidney disease stages 1-5-achievement of K/DOQI target ranges // Nephrol. Dial. Transplant. 2007. Vol. 22. P. 1171 - 1176. doi: 10.1093/ndt/gfl718.
5. Shimada T., Yamazaki Y., Hasegawa H. et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis // J. Bone Miner. Res. 2004. Vol. 19, N 4. P. 429-435. doi: 10.1359/JBMR.0301264.
6. Hu M.C., Kuro-o M, Moe O.W. Secreted Klotho and chronic kidney disease // Advances in Experimental Medicine and Biology. Springer, 2012. Vol. 728. P. 126-157. doi: 10.1007/978-1-4614-0887-1_9.
7. Shimada T., Yamazaki Y., Hasegawa H. et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis // J. Bone Miner. Res. 2004. Vol. 19, N 4. P. 429-435. doi: 10.1359/JBMR.0301264.8. Ben-Dov I.Z., Galitzer H., Lavi-Moshayoff V. et al. The parathyroid is a target organ for FGF-23 in rats // J. Clin. Invest. 2007. Vol. 117, N 12. P. 4003-4008. doi: 10.1172/JCI32409.
9. Cha S.K., Ortega B., Kurosu H. et al. Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1 // Proc. Natl Acad. Sci. USA. 2008. Vol. 105. P. 9805-9810.